References
- Chen K, Kuo SC, Hsieh MC, Mauger A, Lin CM, Hamel E, Lee KH. Antitumor agents. 174. 2′,3′,4′,5,6,7-Substituted 2-phenyl- 1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 40: 2266-2275, 1997 https://doi.org/10.1021/jm980455n
- Chung ML. Synthesis and Anti-Cancer Activity of 2-Phenyl-1,8- naphthyridine-4-one Derivatives. Chung Ang Graduate School Master thesis, 2004
- Hamel E, Lin CM, Plowman J, Wang HK, Lee KH, Paull KD. Antitumor 2,3 Dihydro-2-(aryl)-4(1H)-quinazolinone Derivatives. Interactions with Tubulin. Biochem Pharmacol 51: 53-59, 1996 https://doi.org/10.1016/0006-2952(95)02156-6
- Hastie SB. Interaction of colchicine with tubulin. Pharmacol Ther 51: 377-401, 1991 https://doi.org/10.1016/0163-7258(91)90067-V
- Hour MJ, Huang LJ, Kuo SC, Xia Y, Bastow K, Nakanishi Y, Hamel E, Lee KH. 6-Alkylamino- and 2,3-dihydro-3′-methoxy-2-phenyl- 4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 43: 4479-4487, 2000 https://doi.org/10.1021/jm000151c
- Jackson PL, Scott KR, Southerland WM, Fang YY. Enaminones 8: CoMFA and CoMSIA studies on some anticonvulsant enaminones. Bioor Med Chem 17: 133-140, 2009 https://doi.org/10.1016/j.bmc.2008.11.014
- Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev 4: 253-264, 2004 https://doi.org/10.1038/nrc1317
- Kuo SC, Lee HZ, Juang JP, Lin YT, Wu TS, Chang JJ, Lednicer D, Paull KD, Lin CM, Hamel E, Lee KH. Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted-phenyl)-4- quinolones and related compounds: Identification as antimitotic agents interacting with tubulin. J Med Chem 36: 1146-1156, 1993 https://doi.org/10.1021/jm00061a005
- Lai YY, Huang LJ, Lee KH, Xiao Z, Bastow KF, Yamori T, Kuo SC. Synthesis and biological relationships of 3′,6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents. Bioorg Med Chem 13: 265-275, 2005 https://doi.org/10.1016/j.bmc.2004.09.041
- Li L, Wang HK, Kuo SC, Wu TS, Lednicer D, Lin CM, Hamel E, Lee KH. Antitumor agents. 150. 2′,3′,4′,5′,5,6,7-Substituted 2- phenyl-4-quinolones and related compounds: Their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 37, 1126-1135, 1994 https://doi.org/10.1021/jm00034a010
- Manthey JA, Guthrie N. Antiproliferative Activities of Citrus Flavonoids against Six Human Cancer Cell Lines. J Agric Food Chem 50: 5837-5843, 2002 https://doi.org/10.1021/jf020121d
- Manthey JA, Guthrie N, Grohmann K. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem 8: 135-153, 2001
- Nakamura S, Kozuka M, Bastow KF, Tokuda H, Nishino H, Suzuki M, Tatsuzaki J, Morris Natschke SL, Kuo SC, Lee KH. Cancer preventive agents, part 2: synthesis and evaluation of 2-phenyl- 4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters. Bioorg Med Chem 13: 4396-4401, 2005 https://doi.org/10.1016/j.bmc.2005.04.078
- Park JG, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD, Gazdar AF. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer research 47: 5875-5879, 1987
- Rieger JM, Brown ML, Sullivan GW, Linden J, and Macdonald TL. Design, Synthesis, and Evaluation of Novel A2A Adenosine Receptor Agonists. J Med Chem 44: 531-539, 2001 https://doi.org/10.1021/jm0003642
- Rowinsky EK, Donehower RC. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther 52: 35-84, 1992 https://doi.org/10.1016/0163-7258(91)90086-2
- Shi Q, Chen K, Li L. Antitumor Agents. 154. Cytotoxic and antimitotic flavonols from Polanisia dodecandra. J Nat Prod 58: 475-482, 1995 https://doi.org/10.1021/np50118a001
- SYBYL Molecular Modeling Software. Tripos Inc., St. Louis, USA, 2009
- Verwij J, Clavel M, Chevalier B. Paclitaxel (Taxol) and docetaxel (Taxotere): Not simply two of a kind. Ann Oncol 5: 495-505, 1994
- Xia Y, Yang ZY, Hour MJ, Kuo SC, Xia P, Bastow KF, Nakanishi Y, Nampoothiri P, Hackl T, Hamel E, Lee KH. Antitumor agents. Part 204: Synthesis and biological evaluation of substituted 2-arylquinazolinones. Bioorg Med Chem Lett 11: 1193-1196, 2001 https://doi.org/10.1016/S0960-894X(01)00190-1
- Xia Y, Yang ZY, Xia P, Bastow KF, Tachibana Y, Kuo SC, Hamel E, Hackl T, Lee KH. Antitumor Agents. 181. Synthesis and Biological Evaluation of 6,7,2′,3′,4′-Substituted-1,2,3,4-tetrahydro- 2-phenyl-4-quinolones as a New Class of Antimitotic Antitumor Agents. J Med Chem 41: 1155-1162, 1998 https://doi.org/10.1021/jm9707479
- Zhang SX, Bastow KF, Tachibana Y, Kuo SC, Hamel E, Mauger A, Narayanan VL, Lee KH. Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 42: 4081- 4087, 1999 https://doi.org/10.1021/jm990208z
Cited by
- A Novel Synthesis of 1-Alkyl-2-phenyl-(2,3-dihydro-)1,8-naphthyridin-4-ones from 2-Chloronicotinic Acid vol.36, pp.7, 2009, https://doi.org/10.1002/bkcs.10341